Medical University Of Silesia Katowice Poland
- Address
- Medykow 16, 40-752 Katowice, Poland
Medical University of Silesia - Neurological and Multidisciplinary Research Center
The Medical University of Silesia in Katowice, Poland, stands as a leading academic medical center conducting cutting-edge clinical trials across diverse therapeutic areas. The institution demonstrates particular strength in neurodegenerative disorders and pediatric conditions, with a focus on innovative treatment approaches that address both primary disease symptoms and quality of life outcomes.
- Alzheimer's disease and mild cognitive impairment, investigating neuroprotective therapies to reduce brain atrophy and improve cognitive functions
- Tuberous sclerosis complex with seizures, evaluating cannabidiol-based treatments for behavioral and neurological manifestations
- Pediatric oncology, specializing in Philadelphia chromosome-positive acute lymphoblastic leukemia with targeted tyrosine kinase inhibitor therapy
- ADHD with comorbid type 1 diabetes, comparing pharmacological interventions in complex pediatric cases
The center's research portfolio reflects a commitment to addressing unmet medical needs in both rare neurological conditions and complex comorbid presentations. Their trials employ sophisticated endpoints including synaptic functional connectivity, disease-free survival, and behavioral outcomes, demonstrating expertise in comprehensive patient assessment across multiple domains.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 therapeutic areas and 15 of 23 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Medical University Of Lodz2active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Medical University Of Lodz2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical University Of Silesia Katowice Poland
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Dimethyl Fumarate in Reducing Brain Atrophy and Improving Cognitive Function in Alzheimer's Disease-Related Mild Cognitive Impairment | Medical University Of Lodz | Phase II | Recruiting | Oct 2024 | — |
IMP list
lock Showing 1 of 23 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cannabidiol | 1 | Unknown | 2024-11-12 | 2024-11-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.